Detail akcie Bavarian Nordic online

Business Summary: Bavarian Nordic A/S is a Denmark-based biotechnology company engaged in manufacturing of pharmaceutical preparations. The Company is involved in research and development innovations, production and commercialization of life-saving vaccines based on viral vectors for the delivery of antigens targeting infectious diseases. Bavarian Nordic A/S offers travel health products including cholera, rabies, tick-borne encephalitis and typhoid vaccines, as well as vaccines sold and distributed in selected markets on behalf of third parties. The Company deals with vaccines aimed at improving public health and preparedness. Bavarian Nordic A/S focuses on vaccine solutions that help address the threat of infectious diseases. The Company operates worldwide.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, Bavarian Nordic A/S revenues increased 9% to DKR6.24B. Net income increased 39% to DKR1.38B. Revenues reflect France segment increase from DKR268.8M to DKR723.9M, Germany segment increase of 19% to DKR1.16B. Net income benefited from Labor & Related Expenses in R&D decrease of 33% to DKR261.5M (expense), Unwinding of the discounting effect rela decrease of 93% to DKR5M (expense).